MYLAN LABORATORIES LIMITED, UNIT - 7environmentclearance.nic.in/writereaddata/form-1/...Mylan...
Transcript of MYLAN LABORATORIES LIMITED, UNIT - 7environmentclearance.nic.in/writereaddata/form-1/...Mylan...
MYLAN LABORATORIES LIMITED, UNIT - 7SY. NO. 14, 99 & 100, PHASE II, IDA,
PASHAMAILARAM VILLAGE, PATANCHERU MANDAL,MEDAK DISTRICT, ANDHRA PRADESH
FORM I
Project No. 1113-21-03November 2013
Mylan Laboratories Limited, Unit - 7Sy. No. 14, 99 & 100, Phase II, IDA,Pashamailaram (V), Patancheru (M),Medak (Dist.)- 502 307Phone: +91 040-3049 3876, 8008001511E-mail ID: [email protected]
STUDIES AND DOCUMENTATION BYTEAM Labs and ConsultantsB-115-117 & 509, Annapurna Block,Aditya Enclave, Ameerpet,Hyderabad-500 038.Phone: 040-23748 555/23748616,Telefax: 040-23748666
SUBMITTED TOMINISTRY OF ENVIRONMENT AND FORESTS,
GOVERNMENT OF INDIAPARYAVARAN BHAVAN, LODHI ROAD, NEW DELHI
Mylan Laboratories Limited, Unit - 7
Form I Page 1
APPENDIX – I(See Paragraph – 6)
FORM I
I) Basic InformationS.No. Item Details
1 Name of the Project/s M/s Mylan Laboratories Limited, Unit - 72 S. No in the Schedule 5 f – A category3 Proposed capacity/area/length/tonnage
to be handled/command area/leasearea/number of wells to be drilled
Proposed to enhance the production capacity ofActive Pharma Ingredients (API’s) from 15.51 TPMto 81.52 TPM and addition of Co-Generationpower plant of 5 MW capacity.Cost of the project (Expansion): 40 Crores
4 New/Expansion/Modernization Expansion5 Existing Capacity/Area etc. Existing Capacity: 15.51 TPM
Area Existing: 30.81 Acres6 Category of Project i.e 'A' or 'B' “A”7 Does it attract the general condition? If
yes, please specifyYes.The Unit is Located in Notified Industrial Estate /Area.Critically Polluted Area of Pattancheru andBollaram are located at a distance of 5.5 KM’s fromthe Site.
8 Does it attract the Specific condition? Ifyes, please specify.
No
9 LocationPlot/Survey/Khasra No. Sy. No. 14, 99 & 100, IDAVillage Pashamylaram (V)Tehsil Pattancheru (M)District Medak DistrictState Andhra Pradesh
10 Nearest railway station/airport along withdistance in kms.
Nearest Railway Station is Lingampally at adistance of 20 KM from the site.
11 Nearest Town, City, District Headquartersalong with distance in kms.
Town & District HQ – Sangareddy - 24 KMCity - Hyderabad - 47.3 KM
12 Village Panchayats, Zilla Parishad,Municipal Corporation, Local body(complete postal address with telephonenos. to be given)
Pashamailaram Village
Mylan Laboratories Limited, Unit - 7
Form I Page 2
13 Name of the Applicant G. Srinivas Rao14 Registered Address Mylan Laboratories Limited, Unit – 7, Plot No 14, 99
& 100, Phase – 2, IDA, Pashamylaram (V),Pattancheru (M), Medak District – 502307
15 Address for Correspondence:Name G. Srinivas RaoDesignation(Owner/Partner/CEO) General Manger – EHSAddress Plot No 14, 99 & 100, Phase – 2, IDA,
Pashamylaram (V), Pattancheru (M),Medak District.
Pin Code 502307E-mail [email protected] Number Direct : 040-3049 3876
Mobile : +91 8008001511Fax No. +91 84 5522 4606
16 Details of alternative Sites examined, ifany. Location of these sites should beshown on a topo sheet.
-NA-
17 Interlinked Projects -NA-18 Whether separate application of
interlinked project has been submitted?No
19 If yes, date of submission20 If no, reason21 Whether the proposal involves
approval/clearance under: if yes, detailsof the same and their status to be given.(a) The Forest (Conservation) Act, 1980?(b) The Wildlife (Protection) Act, 1972?(c) The C.R.Z Notification, 1991?
-NA-
22 Whether there is any GovernmentOrder/Policy relevant/relating to the site?
No
23 Forest land involved (hectares) No24 Whether there is any location pending
against the project and /or land in whichthe project is propose to be set up?(a) Name of the Court(b) Case No(c) Orders/directions of the Court, if anyand its relevance with the proposedproject.
No Individual Court case against the Project.
However Green Tribunal Case, W.P. No. 19661 of2002 on the file of Hon’ble High Court of AndhraPradesh / Application No. 90 of 2013 before NGT isfiled against CETP Members.
(Presently our CETP Membership is limited toemergency usage as the plant has ZLD basedeffluent Treatment System)
Mylan Laboratories Limited, Unit - 7
Form I Page 3
(II) Activity
1. Construction, operation or decommissioning of the Project involving actions, which will causephysical changes in the locality (topography, land use, changes in water bodies, etc.)S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate quantities
/rates, wherever possible) with source ofinformation data
1.1 Permanent or temporary change inland use, land cover or topographyincluding increase in intensity ofland use (with respect to local landuse plan)
NO The proposal is for expansion of API’smanufacturing capacity in the existing unit.No additional land. Total Land area afterproposed expansion 30.81 Acres.
1.2 Clearance of existing land, vegetationand buildings?
NO Industrial
1.3 Creation of new land uses? NO1.4 Pre-construction investigations e.g.
bore houses, soil testing?YES Soil Testing completed
1.5 Construction works? YES Construction activity involves creation ofadditional utilities like Boiler, Chilling Plant etcand Co-Generation Power Plant.
1.6 Demolition works? NO
1.7 Temporary sites used forconstruction works or housing ofconstruction workers?
NO Construction labor from local villages shall beemployed.
1.8 Above ground buildings, structures orearthworks including linearstructures, cut and fill or excavations
YES Storage facilities shall be constructed. Nomajor cut and fill or excavation is anticipated.
1.9 Underground works including miningor tunneling?
NO
1.10 Reclamation works? NO1.11 Dredging? NO1.12 Offshore structures? NO1.13 Production and manufacturing
processes?YES Enclosed in Annexure – I
1.14 Facilities for storage of goods ormaterials?
NO Raw materials and solvents shall be storedwith safety precautions.
1.15 Facilities for treatment or disposal ofsolid waste or liquid effluents?
YES Solid waste shall be disposed to endusers/recyclers or sent to incineration.Effluent generated from the plant are treatedand reused. Details presented in Annexure II
1.16 Facilities for long term housing ofoperational workers?
NO Local people shall be employed.
1.17 New road, rail or sea traffic during NO
Mylan Laboratories Limited, Unit - 7
Form I Page 4
construction or operation?1.18 New road, rail, air waterborne or
other transport infrastructureincluding new or altered routes andstations, ports, airports etc?
NO
1.19 Closure or diversion of existingtransport routes or infrastructureleading to changes in trafficmovements?
NO
1.20 New or diverted transmission lines orpipelines?
NO
1.21 Impoundment, damming, culverting,realignment or other changes to thehydrology of watercourses oraquifers?
NO
1.22 Stream crossings? NO1.23 Abstraction or transfers of water
form ground or surface waters?YES Total water required shall increase from 257
KLD to 1166 KLD out of which 816 KLD shall bemet from APIIC and the balance shall berecycled water.
1.24 Changes in water bodies or the landsurface affecting drainage or run-off?
NO
1.25 Transport of personnel or materialsfor construction, operation ordecommissioning?
YES The construction material shall be drawn fromlocal sources within 10 – 15 km. There is notransport of personnel, as the constructionworkers shall be drawn from local villages.
1.26 Long-term dismantling ordecommissioning or restorationworks?
NO
1.27 Ongoing activity duringdecommissioning which could havean impact on the environment?
NO
1.28 Influx of people to an area in eithertemporarily or permanently?
YES The proposed project shall increase theemployment potential and hence may lead tomigration to surrounding villages.
1.29 Introduction of alien species? NO1.30 Loss of native species or genetic
diversity?NO
1.31 Any other actions? NO
Mylan Laboratories Limited, Unit - 7
Form I Page 5
2. Use of Natural resources for construction or operation of the Project (such as land, water, materialsor energy, especially any resources which are non-renewable or in short supply):S.No. Information/checklist confirmation Yes/No Details thereof (with approximate quantities
/rates, wherever possible) with source ofinformation data
2.1 Land especially undeveloped oragricultural land (ha)
NO Existing Unit
2.2 Water (expected source & competingusers) unit: KLD
YES Total water required shall increase from 257KLD to 1166 KLD out of which 816 KLD shall bemet from APIIC and the balance shall berecycled water.(Water Balance Enclosed in Annexure III)
2.3 Minerals (MT) NA2.4 Construction material – stone,
aggregates, sand / soil (expectedsource – MT)
YES Shall be sourced from the local villages.
2.5 Forests and timber (source – MT) NO2.6 Energy including electricity and fuels
(source, competing users) Unit: fuel(MT), energy (MW)
YES The required energy shall be drawn fromAPTRANSCO. Backup DG sets of 3 x 750, 1 x1250 and 2 x 1500 existing and 3 x 1500 KVAproposed, shall be provided to cater to energyrequirement during load shut downs. Theother energy source is Coal fired boilers of 8TPH, 5TPH FO fired boiler existing andproposed 30 TPH coal fired boiler to meet thesteam requirement both for co-generationand process. The required quantity of fuel(coal) is 120TPD and FO is 5 KLD. Diesel forStandby DG sets shall be 150 KL/month.
2.7 Any other natural resources (useappropriate standard units)
NA
Mylan Laboratories Limited, Unit - 7
Form I Page 6
3. Use, storage, transport, handling or production of substances or materials, which could beharmful to human health or the environment or raise concerns about actual or perceived risks tohuman health.S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate
quantities/rates, wherever possible) withsource of information data
3.1 Use of substances or materials, whichare hazardous (as per MSIHC rules) tohuman health or the environment(flora, fauna, and water supplies)
YES Solvents shall be used as reaction media.MSIHC rules shall be followed during storage,transportation and handling of raw materialsand hazardous chemicals.
3.2 Changes in occurrence of disease oraffect disease vectors (e.g. insect orwater borne diseases).
NO
3.3 Affect the welfare of people e.g. bychanging living conditions?
YES Shall increase the employment potential forlocals and affect the living conditions forbetterment.
3.4 Vulnerable groups of people whocould be affected by the project e.g.hospital patients, children, the elderlyetc.,
NO No sensitive receptors are present in theimmediate vicinity of the site. The projectshall not have any significant impact onvulnerable groups of people.
3.5 Any other causes NO
4. Production of solid wastes during construction or operation or decommissioning (MT/month)S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate
quantities/rates, wherever possible) withsource of information data
4.1 Spoil, overburden or mine wastes NO4.2 Municipal waste (domestic and or
commercial wastes)NO Wastes from canteen, other commercial
wastes like paper, empty containers etc. Thecanteen wastes and commercial wastes shallbe in the range of 50 kg/day
4.3 Hazardous wastes (as per HazardousWaste Management Rules)
YES The quantity of hazardous waste generatedduring operation contain salts fromevaporators, stripper distillate, processresidue, and solvent residues, ETP sludge andfiltration media etc. enclosed in Annexure –IV
4.4 Other industrial process wastes YES Enclosed at Annexure IV4.5 Surplus product NO4.6 Sewage sludge or other sludge from
effluent treatmentYES Sludge from Effluent treatment plant and
Salts from MEE & ATFD shall be sent to TSDF.
Mylan Laboratories Limited, Unit - 7
Form I Page 7
4.7 Construction or demolition wastes YES Construction activity involves creation ofadditional utilities like Boiler, Chilling Plant etcand Co-Generation Power Plant.
4.8 Redundant machinery or equipment NO
4.9 Contaminated soils or other materials NO
4.10 Agricultural wastes NO
4.11 Other solid wastes NO Enclosed at Annexure IV
5. Release of pollutants or any hazardous, toxic or noxious substances to air (Kg/hr)S.No. Information/Checklist confirmation Yes/No Details thereof (with approximate
quantities/rates, wherever possible) withsource of information data
5.1 Emissions from combustion of fossilfuels from stationary or mobilesources
YES Coal and FO Shall be used as fuel. Quantity offuel and emissions details are enclosed inAnnexure V
5.2 Emissions from production processes YES Enclosed in Annexure - VI5.3 Emissions from materials handling
including storage or transportNO Material transfer takes place in closed
pipeline systems.5.4 Emissions from construction activities
including plant and equipmentYES Dust may rise during transport of material and
construction activity. The dust emissions shallbe mitigated by water spraying on the roadswithin the premises.
5.5 Dust or odors from handling ofmaterials including constructionmaterials, sewage and waste
YES Dust may rise during transport of material andconstruction activity. The dust emissions shallbe mitigated by water spraying on the roadswithin the premises.
5.6 Emissions from incineration of waste NO5.7 Emissions from burning of waste in
open air (e.g. slash materials,construction debris)
NO
5.8 Emissions from any other sources NO
Mylan Laboratories Limited, Unit - 7
Form I Page 8
6. Generation of Noise and Vibration, and Emissions of Light and Heat:S.No. Information/Checklist
confirmationYes/No Details thereof (with approximate
quantities/rates, wherever possible) with sourceof information data with source of informationdata
6.1 From operation of equipmente.g. engines, ventilation plant,crushers
YES Material transport and construction equipmentshall be source of noise, while transfer pumps,vacuum systems, DG sets are the sources of noiseduring operation.
6.2 From industrial or similarprocesses
YES From Turbine and DG sets, and controlled byproviding Acoustic Enclosures.
6.3 From construction or demolition YES Noise during construction shall be due toconstruction equipment and emergency DG sets.
6.4 From blasting or piling NO
6.5 From construction or operationaltraffic
NO The increased traffic shall not have any significantimpact.
6.6 From lighting or cooling systems NO
6.7 From any other sources NO
7.Risks of contamination of land or water from releases of pollutants into the ground or into sewers,surface waters, groundwater, coastal waters or the sea:S.No. Information/Checklist
confirmationYes/No Details thereof (with approximate
quantities/rates, wherever possible) with sourceof information data
7.1 From handling, storage, use orspillage of hazardous materials
NO All the hazardous materials will be stored in MSdrums, in a covered shed and no contamination ofsoil is expected
7.2 From discharge of sewage orother effluents to water or theland (expected mode and place ofdischarge)
NO All the wastes from domestic operations are sentto Biological treatment in “ZLD” system.
7.3 By deposition of pollutantsemitted to air into the land or intowater
NO All the emissions from process are controlled byproviding control equipment like scrubbers, DustCollectors and emissions from boiler shall becontrolled by providing bag filter.
7.4 From any other sources NO7.5 Is there a risk of long term build
up of pollutants in environmentfrom these sources?
NO
Mylan Laboratories Limited, Unit - 7
Form I Page 9
8.Risk of accidents during construction or operation of the Project, which could affect human health orthe environmentS.No. Information/Checklist confirmation Yes/No Details thereof (with approximate
quantities/rates, whereverpossible) with source ofinformation data
8.1 From explosions, spillages, fires etc fromstorage, handling, use or production ofhazardous substances
YES All Inbuilt Safety precautions will beadopted and there will not be anydamage to environment or humanhealth
8.2 From any other causes NA8.3 Could the project be affected by natural
disasters causing environmental damage(e.g? Floods, earthquakes, landslides,cloudburst etc)?
NO
9.Factors which should be considered (such as consequential development) which could lead toenvironmental effects or the potential for cumulative impacts with other existing or plannedactivities in the localityS. No. Information/Checklist confirmation Yes/No Details thereof (with approximate
quantities/rates, whereverpossible) with source ofinformation data
9.1 Lead to development of supporting.facilities, ancillary development or
development stimulated by the project whichcould have impact on the environment e.g.:
• Supporting infrastructure (roads, powersupply, waste or waste water treatment, etc.)• housing development• extractive industries• supply industries• other
YES The project shall enhance the socioeconomic status of the area byincreasing the demand for housing,improving the employment. Thereare no major support industriesrequired for this plant.
9.2 Lead to after-use of the site, which couldhaven impact on the environment
NO
9.3 Set a precedent for later developments NO9.4 Have cumulative effects due to proximity to
other existing or planned projects with similareffects
NO The baseline environmental statusof the surrounding areas is withinthe prescribed limits as observedfrom the Secondary data.
Mylan Laboratories Limited, Unit - 7
Form I Page 10
(III) Environmental SensitivityS.No. Areas Name/
IdentityAerial distance (within 15 km.)Proposed project location boundary
1 Areas protected under internationalconventions, national or local legislation fortheir ecological, landscape, cultural or otherrelated value
NA
2 Areas which are important or sensitive forecological reasons - Wetlands, watercourses orother water bodies, coastal zone, biospheres,mountains, forests
YES Isnapur Cheru– North– 0.7 Km,Kotta Cheru – Northwest – 2.37 KmPedda Cheru – North – 4 KmLakdaram Cheru – North - 5.3 KmNakkavagu – Northeast – 6.2 Km
3 Areas used by protected, important or sensitivespecies of flora or fauna for breeding, nesting,foraging, resting, over wintering, migration
NA
4 Inland, coastal, marine or underground waters NO5 State, National boundaries NO6 Routes or facilities used by the public for access
to recreation or other tourist, pilgrim areasNO
7 Defense installations NO8 Densely populated or built-up area YES Isnapur is at a distance of 3.5 Km.9 Areas occupied by sensitive man-made land
uses (hospitals, schools, places of worship,community facilities)
NA 3.5 Km from the site
10 Areas containing important, high quality orscarce resources (ground water resources,surface resources, forestry, agriculture,fisheries, tourism, minerals)
NO
11 Areas already subjected to pollution orenvironmental damage. (those where existinglegal environmental standards are exceeded)
YES Patancheru and Bollaram Industrialareas at a distance of 5.5Km.
12 Areas susceptible to natural hazard whichcould cause the project to presentenvironmental problems (earthquakes,subsidence, landslides, erosion, flooding orextreme or adverse climatic conditions)
NO
Mylan Laboratories Limited, Unit - 7
Form I Page 11
(IV) Proposed Terms of Reference for EIA studiesScope of Work of EIA
“...The EIA shall cover the following:Description of the proposed project:The first task:” Description of the proposed project” forms a vital component of the EnvironmentalImpact Assessment (EIA) as it provides the basis for evaluating the likely causes of EnvironmentalImpacts.
Existing Environment and Baseline Conditions:The baseline assessment will be carried out to identify potentially sensitive and critical areas that may beaffected by the project in an area of 10 km surrounding the project location. The critical and sensitivetargets shall be plotted on land use map of project impact area. The existing environment and baselineconditions should be established from:-Analysis of existing information published and secondary data.-Consultation with relevant statutory authorities, and Field visits for supplementation of missing gaps.
The key subject areas which the EIA shall address include Ecology and Nature conservation, Air quality,surface and water quality in project impact area, soil quality, cultural heritage, landscape, land use, noisequality, etc. Natural habitats like national parks, wildlife reserves, sanctuaries, sacred grove, protectedareas, forests, wetlands, major rivers and waterways if any, shall also be identified and marked.
Assessment of Environmental Impacts:Based upon the results from the review of existing information, field visits, site data collection andconsultation, for each component of environment (physical, biological and socio economic) the positive,negative, direct and indirect, temporary and permanent impacts will be evaluated along with anindication of the degree of impact, i.e., whether the impact is significant, moderate, minor or negligible.The degree of impact shall also be quantified by using state of the art air quality impact prediction modelsbased on ISCST3 algorithms.
Environment Management Plan And Mitigation Plan:For each significant negative impact identified, specialist shall work closely with the engineeringteam/technical consultants to suggest practicable measures to avoid or mitigate the impact. Themitigation of environmental impacts will be by three mechanisms.=>Introduction of mitigation features through the engineering practices.=>Implementation of environmental controls during construction and operation.=>Legislative control involving compliance with Indian environmental laws.The Environmental management plan shall include an estimate of capital and recurring costs of mitigationmeasures and will identify the institutional framework for implementation.
Monitoring Plan:Having identified the significant environmental impact that is likely to arise as a result of the project, theproject team shall specify what monitoring is required during the various phases of the project cycle.The monitoring plan will identify parameters and frequency of monitoring and responsible organization.
Mylan Laboratories Limited, Unit - 7
Form I Page 12
I hereby give the undertaking that data and information given in the application and enclosures are trueto the best of my knowledge and belief and I am aware that if any part of the data and informationsubmitted is found to be false or misleading at any stage, the project will be rejected and clearancegiven, if any to the project will be revoked at our risk and cost.
Date:
Place:
Signature of the applicantWith Name and Full Address
(Project Proponent/Authorized Signatory)
M. G. Srinivas RaoGeneral Manager
Mylan Laboratories LimitedUnit – 7, Plot No 14, 99 & 100,
Phase – 2, IDA, Pashamylaram (V),Pattancheru (M),Medak District – 502307
MYLAN LABORATORIES LIMITED, UNIT - 7SY. NO. 14, 99 & 100, PHASE II, IDA,
PASHAMAILARAM VILLAGE, PATANCHERU MANDAL,MEDAK DISTRICT, ANDHRA PRADESH
ANNEXURES
SUBMITTED TOMINISTRY OF ENVIRONMENT AND FORESTS,
GOVERNMENT OF INDIAPARYAVARAN BHAVAN, LODHI ROAD, NEW DELHI
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 1
Loca
tion
Map
of M
ylan
Lab
orat
orie
s Li
mite
d, U
nit -
7
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 2
30
50
5500
LABORAT ORIESLIMITED
30
50
13.5
6.75
6.75
5500
1.65
6.3
MATRIX
6.0
6.0
6.0
6.0
6.0
6.0
5.0
R 2.
5
R 4.
5 (T
YP.
)
3.0
3.75
1000
0
5.0
DN
THIS DRAWING AND DESIGN IS THE PROPERTY OF
AND MUST NOT BE COPIED OR LENT WITHOUT
THEIR PERMISSION IN WRITING.
THIS DRAWING AND DESIGN IS THE PROPERTY OF
AND MUST NOT BE COPIED OR LENT WITHOUT
THEIR PERMISSION IN WRITING.
Mylan Laboratories Limited
EXECUTIVE
CAN
TEEN
SERVICING
BAY
Andh
ra P
rade
sh, I
ndia
.
SIT
E PL
AN.
SCA
LE
1:80
0.
DR
AWN
DAT
E
Plan
t Lay
out o
f Myl
an L
abor
ator
ies
Lim
ited,
Uni
t - 7
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 3
ANNEXURE - I M/s. Mylan Laboratories Limited, Unit – 7 obtained consent for establishment and
operation for Bulk Drugs & intermediates at Sy. No. 14, 99 & 100, Pashamailaram village,
Patancheru mandal, Medak district, Andhra Pradesh. It is proposed to expand the
manufacturing capacity of API’s with addition of 5MW Co-generation power plant. The
expansion entails a capital cost of Rs. 40 crores towards modernization of zero liquid
discharge facility, debottlenecking by way of incorporating the advanced technology. and
state of the art equipment. Manufacturing capacity is presented in Table A-1. The
proposed manufacturing capacity is presented in Table A-2.
Table A-1 Manufacturing Capacity – Permitted
S.No Name of the Product Quantity TPM Kg/day
Regular Products 1 Acyclovir 8 266.67 2 Valacyclovir 1.5 50.00 3 Amlodipine Besilate 2 66.67 4 Clarithromycin 1.5 50.00 5 Loratadine 1 33.33 6 Lansaprazole 0.83 27.67 7 Cetrizine 0.1 3.33
Total -I 14.93 497.67 Campaign Products
1 Fluconazole 0.17 5.67 2 Losartan 0.17 5.67 3 Omeprazole 0.04 1.33 4 Itraconazole 0.04 1.33 5 Terbinafine HCl 0.08 2.67 6 Lisinopril 0.08 2.67 7 Perindopril 0.04 1.33 8 Atorvastatin 0.04 1.33 9 Almotriptan 0.04 1.33
10 Zoledromic Acid 0.04 1.33 11 Des-Loratidine 0.08 2.67 12 Alprazolam 0.08 2.67 13 Lamotrigene 0.17 5.67 14 Resperidone 0.08 2.67 15 Rizatriptan 0.04 1.33 16 Labetelol 0.08 2.67 17 Zolmitriptan 0.04 1.33
Total – II (Worst case any 4) 0.58 19.33 Grand Total (I+II) 15.51 517
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 4
Table A-2 Manufacturing Capacity – After Expansion
S.No Name of the Product Quantity TPM Kg/day
1 Acyclovir 30 1000 2 Aliskiren Hemifumarate 0.1 3.33 3 Almotriptan 0.1 3.33 4 Alprazolam 0.2 6.67 5 Amlodipine Besilate 1 33.33 6 Armodafinil 0.04 1.33 7 Asenapine Maleate 0.1 3.33 8 Atorvastatin 0.01 0.33 9 Azelnidipine 0.02 0.67
10 Azilsartan Medomoximil 0.02 0.67 11 Cetrizine 1 33.33 12 Clarithromycin 4 133.33 13 Cyclobenzaprine 0.11 3.67 14 Des Venlafaxine Fumarate 0.03 1 15 Des-Loratadine 0.1 3.33 16 Dexalansoprozol 0.5 16.67 17 Dronedarone 0.08 2.67 18 Fluconazole 1 33.33 19 Irbesetran 8 266.67 20 Itraconazole 0.05 1.67 21 Labetelol 0.02 0.67 22 Lamotrigene 0.25 8.33 23 Lansaprazole 1 33.33 24 Lisinopril 0.01 0.33 25 llapprazole Sulfide 0.08 2.67 26 lloperidone 0.02 0.67 27 Loratadine 1 33.33 28 Losartan 1 33.33 29 O-Des methyl Venlafaine Succinate 0.03 1 30 Omeprazole 0.03 1 31 Oxybutynim H CL 0.05 1.67 32 Paliperidone 0.03 1 33 Perindopril Arginine 0.03 1 34 Perindropil Erbumine 0.05 1.67 35 Pioglitazone 3 100 36 Pitavastatin 0.1 3.33 37 Rebeprazole 0.15 5 38 Resperidone 0.15 5 39 Rizatriptan 0.1 3.33 40 Rosuvastatin 0.2 6.67 41 Telmesetran 2 66.67 42 Temazepam 0.01 0.33
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 5
43 Terbinafine HCl 0.02 0.67 44 Tetrabenazine 0.02 0.67 45 Valacyclovir 25 833.33 46 Zoledronic Acid 0.01 0.33 47 Zolmitriptan 0.1 3.33 48 Validation products 0.6 20 Total 81.52 2717.33 Co-Generation Power Plant 5 MW
List of By-Products (Tentative)
S.No Name of the Byproduct Quantity (Kg/day)
Name of the Product
1 1,3 Di Cyclo Hexyl Urea 1000 Valacyclovir
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 6
Process Description of Acyclovir
Chemical Reaction of Acyclovir
PT SA
(CH3CO)2O
1,3-DIOXOLANE
O O
SODIUM ACET AT E
(CH3CO)2O
CH3CO-O-CH2-O-CH2CH2-O-COCH3
DIOXOLANE DIACETATE
CH3CO-O-CH2-O-CH2CH2-O-COCH3
DIOXOLANE DIACETATE
DMA
[H2O]
HN
N
O
H2N
N
NH
GUANINE
PT SA
T OLUENE
CH2OCH2CH2OAC
HN
N
O
CH3COHN
N
N
DIACETYL ACYCLOVIR
HN
N
O
CH3COHN
N
N
DIACETYL GUANINE
COCH3
HN
N
O
CH3COHN
N
N
DIACETYL GUANINE
COCH3
Process Description for Acyclovir
Guanine is reacted with acetic anhydride to form diacetyl guanine. Diacetyl guanine is
condensed with dioxolane diacetate for form stage II product. Stage II product is
hydrolysed under basic conditions to give crude Acyclovir. Crude Acyclovir is
purified with water to give Acyclovir. The process flow diagram is presented in Fig
A-1 and material balance is presented in Table A-3.
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 7
Guanine Diacetayl Guanine Acetic anhydride
PTSA Recoveries(-)Acetone Stage - I Acetone
Acetic anhydride Organic Resiude
Diacetayl Guanine Diacetyl acyclovir Dioxolane Diacetate Crude 2 nd crop
Toluene Recoveries(-)PTSA Stage - II Toluene
Acetone Acetone
Organic residue
Diacetyl acyclovir Acyclovir Crude DMA 2nd crop
Water Waste WaterAcetone
Stage - III Recoveries(-)DMAAcetone
Organic residue
Acyclovir Crude Water 2nd crop
Carbon Waste WaterHyflo Recoveries(-)
Sodium Diothionite (hydrose ) Stage - IV Acetone Acetone Organic residue
Spent carbon
Acyclovir
Process Flow Sheet - Acyclovir
Fig A-1 Process Flow Diagram of Acyclovir
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 8
Table A-3 Material Balance for Acyclovir Stage: I
Input Output S.No Name of the Material Per Batch Name of the Material Per Batch
Kgs Kgs 1 Guanine 114 Diacetayl Guanine 162 2 Acetic anhydride 463.70 3 PTSA 4.55 Waste Water 0 4 Acetone 170.86
Solid Waste Recoveries(-) Organic Resiude 103.10 Acetone 162 Organic waste Acetic anhydride 325 Spent carbon Emissions Acetone 1 Total 265.88 265.9
Stage: II
Input Output S.No Name of the Material Per Batch Name of the Material Per Batch
Kgs Kgs 1 Diacetayl Guanine 162 Diacetyl acyclovir 166 2 Dioxolane Diacetate 224 Crude 2 nd crop 219.8 3 Toluene 571 Waste Water 0.00 4 PTSA 8 5 Acetone 197
Solid Waste Organic residue 34.55 Spent carbon 0 Recoveries(-) Toluene 542.49 Acetone 186.9 Emissions Toluene 2.86 Acetone 0.98 Total 424.44 424.44
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 9
Stage: III
Input Output S.No Name of the Material Per Batch Name of the Material Per Batch
Kgs Kgs 1Diacetyl acyclovir 166 Acyclovir Crude 121 2DMA 296 2nd crop 44 3Water 166 Waste Water 166.2 4Acetone 131 DMA 5.92
Acetone 0.7 Solid Waste Organic residue 13.52 Spent carbon 0.0 Recoveries(-) Emissions DMA 281.1 DMA 1.48 Acetone 124.6 Acetone 0.66 Total 353.77 353.77
Stage: IV
Input Output S.No Name of the Material Per Batch Name of the Material Per Batch
Kgs Kgs 1Acyclovir Crude 121 Acyclovir 100 2Water 4510 2nd crop 21 3Carbon 71.78 Waste Water 4509.83 4Hyflo 14.4 Acetone 3.84 5Sodium Diothionite (hydrose ) 2 Sodium compound 0.5 6Acetone 192
Solid Waste Recoveries(-) Organic residue 6.53 Acetone 183 Spent carbon 86 Emissions Acetone 0.96 Total 4729.22 4729.22
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 10
ANNEXURE – II: Wastewater Treatment Facilities
The effluent generated from the proposed expansion of M/s. Mylan Laboratories Limited,
Unit – 7 is mainly from process, washings, scrubbers, cooling towers & boiler blow downs
and domestic effluent. Effluent from process, HTDS effluent sent to Stripper, Multiple
Effect Evaporator followed by ATFD, Biological treatment and RO. LTDS effluent from
process, washings, scrubbers, Solvent recovery system, DM rejects, Cooling towers, boiler
bow downs, detoxification effluent, ZLD washings and domestic effluents shall be sent to
Biological treatment system followed by RO. The treated effluent shall be reused for
cooling towers. Total Effluent generated and mode of treatment before and after
expansion is presented in Table A-4 and quantity and quality of effluent generated from
process after expansion is presented in Table A-5.
Table A-4 Quantity of Effluent Generated – After Expansion (Tentative)
Description of Effluent Quantity (KLD) Mode of Final Disposal Permitted After
Expansion HTDS Effluents
Process 42 75 Treated in effluent treatment plant consist of Stripper, MEE, ATFD and Biological treatment followed by RO.
RO Permeate reused for cooling tower makeup and RO rejects sent to MEE.
Total HTDS 42 67 LTDS Effluents
Process Effluent 12 72 Biological treatment followed by RO. RO Permeate reused for cooling tower makeup and RO rejects sent to MEE.
Washings Effluent 10 Scrubber Effluent 5 Solvent recovery plant 10 Boiler 42 20 Cooling Tower 72 DM Plant, Softener & Purified water system
35
Detoxification 5 ZLD Washings 10 Domestic 15 40 Total LTDS 111 279
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 11
Table A-5 Quantity and Quality of Effluent Generated from Process (Tentative)
Waste Water Segregation - (Criteria: TDS < 5000 mg/lt.) LTDS Effluents HTDS Effluents
S.No Description Quantity Ltrs
COD KGD
COD mg/l
TDS KGD
TDS mg/l
Quantity Ltrs
COD KGD
COD mg/l
TDS KGD
TDS mg/l
1 Acyclovir 38625 112.53 2913 4.12 107 0 0 0 0 2 Valacyclovir 30238 433.84 14347 0 0 8499 568.09 66844 48.33 5687 3 Amlodipine Besilate 954 36.67 38413 0 0 0 0 0 0 4 Clarithromycin 0 0 0 0 0 5848 213.4 36491 150.32 25704 5 Loratadine 0 0 0 0 0 4269 192.18 45022 365.68 85668 6 Lansaprazole 820 57.63 70253 0 0 3732 57.14 15310 136.63 36610 7 Cetrizine 0 0 0 0 0 2713 130.42 48064 146.02 53813 8 Fluconazole 0 0 0 0 0 2317 146.83 63361 100.33 43295 9 Losartan 0 0 0 0 0 1670 69.07 41355 83.58 50047
10 Telmesetran 0 0 0 0 0 1582 57.47 35350 43.86 26974 11 Irbesartan 0 0 0 0 0 3934 126.5 31475 85.2 21199 12 Omeprazole 19 0.21 11048 0.06 3107 69 2.82 40777 2.07 29949 13 Itraconazole 2 0.77 331819 0 0 36 0.51 14116 1.01 27723 14 Terbinafine HCl 0 0 0 0 0 29 0.77 26718 1.94 67044 15 Lisinopril 6 0.07 11657 0 0 128 2.09 16310 2.73 21342 16 Perindopril Arginine 13 1.55 115702 0 0 49 3.62 73363 2.9 58795 17 Atorvastatin 0 0 0 0 0 16 0.47 28467 0.42 25650 18 Almotriptan 0 0 0 0 0 908 28.39 31251 60.09 66154 19 Zoledronic Acid 10 0.02 1691 0 0 9 0.5 53048 1.02 107736 20 Des-Loratadine 0 0 0 0 0 228 3.75 16453 3.33 14638 21 Alprazolam 250 11.97 47856 0 0 346 8.87 25656 18.38 53145 22 Lamotrigene 0 0 0 0 0 1005 16.27 16195 26.73 26608 23 Resperidone 0 0 0 0 0 186 3.52 18943 11.65 62748 24 Rizatriptan 0 0 0 0 0 1111 91.02 81904 115.3 103757 25 Labetelol 0 0 0 0 0 29 2.48 85939 0.57 19873 26 Zolmitriptan 14 1.2 86687 0 0 640 18.07 28219 33.78 52754
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 12
27 Pitavastatin 329 2.07 6286 1.33 4047 1018 47.71 46866 55.08 54114 28 lloperidone 0 0 0 0 0 7.3 0.08 10829 0.35 47615 29 Azelnidipine 0 0.02 38961 0 0 4 1.09 270789 0.11 27227 30 Rebeprazole 0 0 0 0 0 439 7.88 17956 67.23 153291 31 Dexalansoprozol 17 5.73 335179 0.05 3119 4111 329.04 80034 120.91 29410 32 Rosuvastatin 0 0 0 0 0 2506 59.04 23559 137.51 54868 33 Oxybutynim H CL 22 0.76 34164 0 0 73 7.8 106294 10.85 147836 34 Pioglitazone 0 0 0 0 0 20128 501.12 24896 1150.18 57142 35 Paliperidone 0 0 0 0 0 47 1.84 39541 6.38 137064 36 O-Des methyl
Venlafaine Succinate 0 0 0 0 0 86 4.24 49058 6.56 75998
37 Cyclobenzaprine 3 0.27 94340 0 0 71 1.1 15390 13.41 188159 38 Armodafinil 259 4.34 16727 0 0 222 13.19 59518 10.96 49470 39 llapprazole Sulfide 0 0 0 0 0 599 41.39 69094 12.64 21100 40 Dronedarone 0 0 0 0 0 99 2.46 24821 2.78 28067 41 Des Venlafaxine
Fumarate 0 0 0 0 0 1454.4 87.19 59949 108.93 74894
42 Temazepam 0.4 0.01 11224 0 1202 14.3 0.23 15776 0.6 41945 43 Perindropil Erbumine 0 0 0 0 0 38.4 1.55 40301 2.31 60157 44 Asenapine Maleate 0 0 0 0 0 4315.9 78.88 18277 1203.88 278940 45 Tetrabenazine 0 0 0 0 0 22.7 2.41 106070 4.84 212824 46 Aliskiren
Hemifumarate 0 0 0 0 0 79.2 3.47 43814 2.01 25320
47 Azilsartan Medomoximil
0 0 0 0 0 11.9 0.27 22308 0.37 30776
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 13
ANNEXURE – III: Water Balance
The total water requirement shall increased from 257 KLD to 1175 KLD after expansion
out of which 821 KLD shall be drawn from APIIC and balance shall be recycled water. The
water balance for daily consumption after expansion is presented in Table A-6.
Table A-6 Total Water Balance – After Expansion (Tentative)
Purpose INPUT (KLD) OUTPUT (KLD) Fresh Water
Recycled Water
Loss Wastewater
Process 138 147* Washings 10 10 Scrubber 5 5 Solvent recovery plant 10 10 Boiler 216 196 20 Process & Utility RO rejects to Cooling tower make-up
196 354 580 72
Cooling Tower 106 DM Plant, Softener & Purified water system
35 35
Detoxification 5 5 ZLD Washings 10 10 Water for gardening 50 50 Domestic 40 40 Gross Total 821 354 826 354 Total 1175 1180
* Process effluents contain soluble raw materials, byproducts, solvents etc.
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 14
ANNEXURE – IV: Solid Waste
Solid wastes are generated from the process shall be sent to TSDF/ Cement Industries for
Co-incineration. Stripper distillate shall send to TSDF/ Cement Industries for Co-
incineration. Evaporation salts from MEE and ATFD and ETP Sludge shall be sent to
TSDF. The total solid waste generated and mode of disposal is presented in Table A-7.
Table A-7 Solid Waste Details – After Expansion (Tentative) S.No. Description of waste UOM Permitted After
Expansion Disposal Point
1.Hazardous Waste with Disposal Option : 1 Spent Carbon TPM 15 45 TSDF for incineration /
Cement Industry for co-incineration
2 Process Organic Waste TPM 37.65 70 3 Distillation Bottom Residue TPM 22.5 195 4 Spent Mixed Solvents (Colored) KL/Month 300 5 Stripper Distillate KL/Month 45 6 Process Inorganic Salts TPM 12.39 25 TSDF for secure Landfill 7 ETP Sludge TPM 30 65 8 Forced Evaporation Salts TPM 20.61 132 9 Thermocol TPM 10 10 Insulation Waste TPM 10 11 Off specified & Discarded Raw
materials, lab chemicals & products
TPM 2
12 Used Filters (HEPA, Oil Filters etc.)
No's / Month
20
13 Discarded PPE, Shoe covers, Lab vials, tissue papers etc...
TPM 5
14 DM Plant & Softner Plant Resins TPM 2 15 Laboratory vials / Injection Vials Kgs /
Month 100 TSDF for incineration
16 By-products TPM 0 45 Sale to Preprocessors 2.Hazardous Waste with Recycling Option :
17 Used Oil / Waste Lubricating oil Ltrs/Month 900 3000 Authorized recyclers
18
Detoxified Container No/month 300 3000 Sale after detoxification Glass Bottles Nos/
Month 0 500
Detoxified Liners TPM 30 19 Spent Mixed Solvents /
Recovered Solvents (Colorless) KL/Month 450 450 Sale to authorized
recyclers 20 Lead acid batteries No/year 75 Authorized recyclers 21 Electrical & Electronic Waste (E -
Waste) TPA 15 Authorized Off - Site
facility
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 15
Non Hazardous Solid Waste 22 Coal Ash TPM 1000 Brick Kilns 23 Paper waste TPM 10 Sale to recyclers 24 Wood waste , carton boxes TPM 10 Sale to recyclers 25 Packing materials TPM 25 Sale to recyclers 26 Broken glass TPM 5 Sale to recyclers 27 Metal scrap (MS/GI/SS etc...) TPM 25 After detoxification to
sale 28 Canteen waste TPM 5 Composting at site /
Piggeries
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 16
ANNEXURE – V: Stack Emissions Details
The sources of air pollution in the plant are from the existing 8 TPH Coal fired boiler,
5TPH FO fired boiler and proposed 30 TPH coal fired boiler to meet the steam
requirement both for co-generation and process and existing backup DG sets of 3 x 750, 1 x
1250 and 2 x 1500 and proposed 3 x 1500 KVA, to cater to energy requirement during load
shut downs. The proposed air pollution control equipment for coal fired boiler is bag
filter. DG sets shall be provided with stack heights based on the CPCB formula for
effective stack height. The emission rates of SPM, SO2, NOx and SPM from each stack are
presented in Table A-8.
Table A-8 Stack Emission Details
S. No
Stack Connected to
Stack Ht (m)
Dia of stack at top(m)
Temp. of exhaust
gases (0C)
Exit Velocity (m/sec)
Pollutant Emission Rate
(g/sec) SPM SO2 NOx
Permitted 1 8TPH Coal fired
Boiler* 30 1.5 130 6.05 0.6 0.7 0.25
2 5 TPH FO fired Boiler*
30 1.5 146 5.57 0.09 0.33 0.17
3 3 x 750KVA DG Sets**
8.5 0.2 165 6.2 0.01 0.02 0.03
4 1 x 1250KVA DG Set**
11 0.2 180 8.8 0.01 0.03 0.04
5 2 x 1500KVA DG Sets**
12 0.2 151 10 0.02 0.03 0.05
Proposed 1 30TPH Coal
Fired Boiler 42 2.0 200 15 2.5 4.5 5.1
2 3 x 1500KVA DG Sets**
12 0.2 151 10 0.02 0.03 0.04
*Boilers shall be kept as standby **DG sets will be used during load shut down by APTRANSCO.
MylanLaboratoriesLimited,Unit‐7FormIAnnexures
Page 17
ANNEXURE – VI: Process Emissions Details
Table A-9 Quantity of Process Emission Generated and Mode of Treatment/Disposal (Tentative)
S.No. Name of product Stage Name of the gas Quantity (Kg/day)
Treatment/Disposal
1 Valacyclovir II Hydrogen 1296 Latout into atmosphere through water column
2 Clarithromycin I Carbondioxide 3.3 Latout into atmosphere safely
3 Loratadine I Hydrogen Chloride
22 Sent to Scrubber
4 Omeprazole I Hydrogen Chloride
0.42 Sent to Scrubber
5 Lisinopril I Carbondioxide 0.22 Latout into atmosphere safely
I Hydrogen 0.07 Latout into atmosphere through water column
6 Perindopril Arginine
II Hydrogen 0.56 Latout into atmosphere through water column
7 Atorvastatin I Carbondioxide 0.03 Latout into atmosphere safely
8 Almotriptan II Carbondioxide 2.5 Latout into atmosphere safely
III Carbondioxide 3.33 Latout into atmosphere safely
9 Lamotrigene II Carbondioxide 8.33 Latout into atmosphere safely
10 Rizatriptan II Hydrogen 0.83 Latout into atmosphere through water column
11 Labetelol II Hydrogen 0.2 Latout into atmosphere through water column
12 Rosuvastatin I Carbondioxide 3.33 Latout into atmosphere safely
13 Paliperidone II Carbondioxide 0.83 Latout into atmosphere safely
14 Dronedarone I Carbondioxide 0.37 Latout into atmosphere safely
MYLAN LABORATORIES LIMITED, UNIT - 7SY. NO. 14, 99 & 100, PHASE II, IDA,
PASHAMAILARAM VILLAGE, PATANCHERU MANDAL,MEDAK DISTRICT, ANDHRA PRADESH
STUDIES AND DOCUMENTATION BYTEAM Labs and ConsultantsQCI: MoE&F OM, List A-1, S.No. 150.(An ISO 9001:2008, ISO 14001:2004 &OHSAS 18001:2007 Certified Organization)B-115, Annapurna Block, Aditya EnclaveAmeerpet, Hyderabad-500 038.Phone: 040-23748 555/616,Telefax: 040-23748666Email: [email protected]